BCL2 and neoplasm: Since we demonstrated both an increased macrophage infiltration into the tumor and an upregulation of Bcl-2 within the tumor as potential mechanisms explaining tumor cell resistance to Regorafenib, we sought to elucidate whether both mechanisms are connected, in particular, if Bcl-2 upregulation is mediated by tumor-infiltrating macrophages.